Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    general medicine

    Systemic amyloidosis

    Also known as: Systemic amyloid disease, Multisystem amyloidosis, Systemic AL amyloidosis, Systemic light-chain amyloidosis

    Systemic amyloidosis is characterized by the extracellular deposition of misfolded protein fibrils within various organ systems, with clinical manifestations contingent upon the amyloid precursor protein and the specific tissues involved. Immunoglobulin light-chain (AL) amyloidosis represents a distinct subtype rather than an overarching descriptor for all systemic presentations. Affection of the myocardium, renal parenchyma, peripheral nerves, hepatic tissue, or gastrointestinal tract frequently results in overlapping clinical features, necessitating specialist diagnostic procedures and targeted pharmacotherapy. Current literature emphasises risks including diagnostic delay, orthostatic hypotension, congestive cardiac failure, and atypical abdominal presentations; however, no evidence supports Chinese medicine as a primary therapeutic modality. Acupuncture or pattern-based interventions may be considered for adjunctive supportive care in medically stable patients, though the cited evidence does not indicate that acupuncture or herbal medicine can reduce amyloid burden, restore physiological organ function, or increase survival rates.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Adhere strictly to sodium and fluid restriction protocols established by the specialist; do not increase fluid intake to address 'dryness' in a TCM context without prior medical authorisation.
    • •Transition slowly from a seated or supine position to standing and utilise physical support if light-headedness occurs; report recurrent orthostatic symptoms promptly to the medical practitioner.
    • •Calibrate physical exertion according to the parameters defined by the cardiology or rehabilitation team, and cease activity immediately upon the onset of dizziness, dyspnoea, or precordial discomfort.
    • •Maintain comprehensive documentation of all clinical symptoms, prescribed pharmacotherapy, and supplements; perform regular weight monitoring if indicated by the treating clinical team.

    Cautions & Contraindications

    See sources
    • •Defer elective acupuncture and herbal initiation during recurrent syncope, symptomatic hypotension or suspected decompensated heart failure; arrange medical assessment. The cited report supports the seriousness of these findings, not a tested acupuncture contraindication.[]
    • •Avoid abdominal needling over enlarged organs, unexplained abdominal masses or recent operative sites, and defer treatment for acute abdominal pain. This conservative precaution reflects the reported organ enlargement and splenic rupture, not procedural safety evidence.[]
    • •Do not replace or delay specialist disease-specific treatment with pattern-based care. The supplied reports describe rapid deterioration and a need for timely medical treatment, not herbal efficacy or interaction safety.[,]

    When to reassess or seek care again

    See sources

    Agree one or two symptom goals before treatment, such as nausea severity on a 0–10 scale, appetite, stool frequency or sleep interruption. Review within 1–2 weeks and before every session for new dizziness, breathlessness, swelling or abdominal symptoms. Stop adjunctive treatment and refer promptly for deterioration; discontinue or reconsider after 2–4 weeks without meaningful symptomatic benefit. Organ function and amyloid treatment response remain specialist-monitored outcomes.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Frontiers in psychiatry · 2026
    2. Frontiers in genetics · 2026
    3. Frontiers in medicine · 2026
    4. Medicine · 2025

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.